INV vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While revenue growth is robust at 80.30%, the valuation is disconnected from reality with a Price/Sales ratio of 169.02 and a catastrophic operating margin of -3859.12%. Despite a 'strong_buy' analyst consensus from a very small sample, heavy insider selling of $10.16M and a bearish technical trend suggest a high-risk speculative environment.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
INV vs JPM: Head-to-Head Comparison
This page compares Innventure, Inc. (INV) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.